Those Fleeting, Pesky Coronavirus Antibodies Are Going to Make Developing a Vaccine Awfully Difficult
Those Fleeting, Pesky Coronavirus Antibodies Are Going to Make Developing a Vaccine Awfully Difficult
KNX 1070—Senior Investigator Warner Greene, MD, PhD, comments on the recent findings that antibodies against SARS-CoV-2, the cause of COVID-19, disappear quickly from people's blood after they recover from infection, and discusses the implications for vaccine development.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab